Journal of Basic and Clinical Pathophysiology

Journal of Basic and Clinical Pathophysiology

Effect of simultaneous injection of l-arginine in dorsal hippocampus and laterodorsal periaqueductal gray matter on morphine-induced analgesia in rat’s formalin test

Document Type : Research Paper

Authors
Mahboobeh Hashemi 1
Manizheh Karami 1
Mohammadreza Zarrindast 2
1 Department of Biology, Faculty of Basic Sciences, Shahed University, Tehran, Iran
2 Department of Pharmacology, School of Pharmacy, Tehran University of Medical Sciences,Tehran, Iran
10.22070/jbcp.2021.14570.1144
Abstract
Background and Objective: Injection of l-arginine, a precursor of nitric oxide, in the rat’s hippocampus or periaqueductal gray matter reduces the analgesic effect of morphine on formalin-induced pain, but the effect of simultaneous injection of the substance in both areas have not been shown as our purpose of this research.
Materials and Methods: Wistar rats were used as control, morphine, and l-arginine groups. The rats were simultaneously cannulated in two areas of the dorsal hippocampus and laterodorsal PAG. One week later, the control animals received 50 μl of 2.5% formalin in the paw of the left foot under restrainer. The morphine group 10 min before formalin received the opioid (6 mg/kg, intraperitoneally). Other groups took l-arginine (0.25-2 µg/rat) in only one area (d hippocampus or ld PAG), prior to morphine administration. The effective dose of l-arginine (0.5 µg/rat) simultaneously was injected in both areas. The findings were analyzed by analysis of variance (ANOVA) under α=0.05.
Results: Morphine induced analgesic response. Injection of NO precursor both separately and simultaneously in the two nuclei reduced morphine-induced analgesia.
Conclusion: Increasing levels of NO due to exclusive or concurrent injection of l-arginine in the areas likely antagonize the morphine response.
Keywords
L-arginine
PAG
Hippocampus
Formalin test
  1. Tenopoulou M, Doulias PT. Endothelial nitric oxide synthase-derived nitric oxide in the regulation of metabolism. F1000 Research 2020; 9:F1000 Faculty Rev-1190. doi: 10.12688/f1000research.19998.1. eCollection 2020.
  2. Ghimire K, Altmann HM, Straub AC, Isenberg JS. Nitric oxide: what's new to NO?. American Journal of Physiology 2017; 312(3):C254-C262. doi: 10.1152/ajpcell.00315.2016.
  3. Zhang N, Beuve A, Townes-Anderson E. The nitric oxide-cGMP signaling pathway differentially regulates presynaptic structural plasticity in cone and rod cells. The Journal of Neuroscience 2005 ; 25(10):2761-70. doi: 10.1523/JNEUROSCI.3195-04.2005.
  4. Cury Y, Picolo G, Gutierrez V. Pain and analgesia: The dual effect of nitric oxide in the nociceptive system. Nitric Oxide 2011; 25(3):243-54. doi: 10.1016/j.niox.2011.06.004.
  5. LIU M-G, Chen J. Roles of the hippocampal formation in pain information processing. Neuroscience Bulletin 2009; 25(5):237-66. doi: 10.1007/s12264-009-0905-4.
  6. Toda N, Kishioka S, Hatano Y, Toda H. Modulation of opioid actions by nitric oxide signaling. Anesthesiology 2009; 110(1):166-81. doi: 10.1097/ALN.0b013e31819146a9.
  7. Nazeri M, Razavinasab M, Abareghi F, Shabani M. Role of nitric oxide in altered nociception and memory following chronic stress. Physiology Behavior 2014; 129:214-20. doi: 10.1016/j.physbeh.2014.02.054.
  8. TadeuMiguela T, LuizNunes-de-Souza R. Defensive-like behaviors and antinociception induced by NMDA injection into the periaqueductal gray of mice depend on nitric oxide synthesis. Brain Research 2006; 1076(1):42-8. doi: 10.1016/j.brainres.2005.12.095. Epub 2006 Feb 13.
  9. Emmanouil DE. Nitrous oxide-antinociception is mediated by opioid receptors and nitric oxide in the periaqueductal gray region of the midbrain. European Neuropsychopharmacology 2008; 18(3):194-9. doi: 10.1016/j.euroneuro.2007.06.008.
  10. Benarroch EE. Periaqueductal gray; An interface for behavioral control. Neurology 2012; 78(3):210-7. doi: 10.1212/WNL.0b013e31823fcdee.
  11. Tyrtyshnaia A, Manzhulo I. Neuropathic Pain Causes Memory Deficits and Dendrite Tree Morphology Changes in Mouse Hippocampus. Journal of Pain Researcg 2020; 13:345-354. doi: 10.2147/JPR.S238458.
  12. Hafeshjani ZK, Karami M, Biglarnia M. Nitric oxide in the hippocampal cortical area interacts with naloxone in inducing pain. Indian Journal of Pharmacology 2012; 44(4):443-7. doi: 10.4103/0253-7613.99299.
  13. Hashemi M, Karami M, Zarrindast MR, Sahebgharani M. Role of nitric oxide in the rat hippocampal CA1 in morphine antinociception. Brain Research 2010; 1313:79-88. doi: 10.1016/j.brainres.2009.11.020.
  14. Huang J, Gadotti VM, Chen L, Souza IA, Huang S, Wang D, Ramakrishnan C, Deisseroth K, Zhang Z, Zamponi GW. A neuronal circuit for activating descending modulation of neuropathic pain. Nature Neuroscience 2019; 22(10):1659-1668. doi: 10.1038/s41593-019-0481-5.
  15. Lin J, Zhang X, Li C, Zhang Y, Lu H, Chen J, Li Z, Yang X, Wu Z. Evodiamine via targeting nNOS and AMPA receptor GluA1 inhibits nitroglycerin-induced migraine-like response. Journal of Ethnopharmacology 2020; 254:112727. doi: 10.1016/j.jep.2020.112727.
  16. Ally A, Powell I, Ally MM, Chaitoff K, Nauli SM. Role of neuronal nitric oxide synthase on cardiovascular functions in physiological and pathophysiological states. Nitric Oxide 2020; 102:52-73. doi: 10.1016/j.niox.2020.06.004.
  17. Thompson JM, Neugebauer V. Cortico-limbic pain mechanisms. Neuroscience Letter 2019; 702:15-23. doi: 10.1016/j.neulet.2018.11.037.
Journal of Basic and Clinical Pathophysiology
Volume 9, Issue 1
May 2021
Pages 52-57